The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D
Open accessAbstract
Estrogen receptor (ER) β counteracts the activity of ERα in many systems. In agreement with this, we show in this study that induced expression of ERβ in the breast cancer cell line T47D reduces 17β-estradiol-stimulated proliferation when expression of ERβ mRNA equals that of ERα. Induction of ERβ reduces growth of exponentially proliferating cells with a concomitant decrease in components of the cell cycle associated with proliferation, namely cyclin E, Cdc25A (a key regulator of Cdk2), p45 Skp2 (a key regulator of p27 Kip1 proteolysis), and an increase in the Cdk inhibitor p27 Kip1 . We also observed a reduced Cdk2 activity. These findings suggest a possible role for ERβ in breast cancer and imply that ERβ-specific ligands may reduce proliferation of ER-positive breast cancer cells through actions on the G 1 phase cell-cycle machinery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer
Signoretti, S., Marcotullio, L. D., Richardson, A. L., Ramaswamy, S., Isaac, B. M., Rué, M., Monti, F., Loda, M. F., & Pagano, M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15795 · Cited by 257
RetractedDifferential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
Self-citationPostmenopausal Hormone Replacement Therapy: Scientific Review
Nelson, H. D., Humphrey, L. L., Nygren, P., Teutsch, S. M., & Allan, J. D. (2002) · JAMA · doi:10.1001/jama.288.7.872 · Cited by 990
Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice
Ortega, S., Prieto, I., Odajima, J., Martín, A., Dubus, P., Sotillo, R., Barbero, J. L., Malumbres, M., & Barbacid, M. (2003) · Nature Genetics · doi:10.1038/ng1232 · Cited by 796
Cyclin E Ablation in the Mouse
Geng, Y., Yu, Q., Sicinska, E., Das, M., Schneider, J. E., Bhattacharya, S., Rideout, W. M., Bronson, R. T., Gardner, H., & Sicinski, P. (2003) · Cell · doi:10.1016/s0092-8674(03)00645-7 · Cited by 660
Estrogen receptor (ER) β, a modulator of ERα in the uterus
Weihua, Z., Saji, S., Mäkinen, S., Cheng, G., Jensen, E. V., Warner, M., & Gustafsson, J.-Å. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.5936 · Cited by 507
Self-citationJackson, T. A., Richer, J. K., Bain, D. L., Takimoto, G. S., Tung, L. W., & Horwitz, K. B. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.693 · Cited by 478
Proliferation of cancer cells despite CDK2 inhibition
Tetsu, O., & McCormick, F. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00053-9 · Cited by 466
Ogawa, S. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.15.3505 · Cited by 448
Prall, O. J., Sarcevic, B., Musgrove, E. A., Watts, C. W., & Sutherland, R. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10882 · Cited by 444
Opposing Action of Estrogen Receptors α and β on Cyclin D1 Gene Expression
Liu, M.-M., Albanese, C., Anderson, C. M., Hilty, K., Webb, P., Uht, R. M., Price, R. H., Pestell, R. G., & Kushner, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201829200 · Cited by 422
Altucci, L., Addeo, R., Cicatiello, L., Dauvois, S., Parker, M., Truss, M., Beato, M., Sica, V., Bresciani, F., & Weisz, A. (1996) · PubMed · Cited by 343
Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells
Doisneau-Sixou, S. F., Sergio, C. M., Carroll, J. S., Hui, R., Musgrove, E. A., & Sutherland, R. L. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100179 · Cited by 333
Dubik, D., Dembinski, T. C., & Shiu, R. P. C. (1987) · PubMed · Cited by 276
c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry
Prall, O. W. J., Rogan, E. M., Musgrove, E. A., Watts, C. K. W., & Sutherland, R. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4499 · Cited by 267
Estrogen receptor beta in breast cancer.
Palmieri, C., Cheng, G. J., Saji, S., Zelada-Hedman, M., W√§rri, A., Weihua, Z., Van Noorden, S., Wahlstrom, T., Coombes, R. C., Warner, M., et al. (2002) · Endocrine-related cancer · doi:10.1677/erc.0.0090001 · Cited by 257
Self-citationFoster, J. S. (1996) · Molecular Endocrinology · doi:10.1210/me.10.5.488 · Cited by 244
Self-citationLin, C. Q., Singh, J., Murata, K., Itahana, Y., Parrinello, S., Liang, S. H., Gillett, C., Campisi, J., & Desprez, P. Y. (2000) · PubMed · Cited by 229
Bukholm, I. R. K., Bukholm, G., & Nesland, J. M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1311 · Cited by 205
Estrogens and cell-cycle regulation in breast cancer
Foster, J. S., Henley, D. C., Ahamed, S., & Wimalasena, J. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00436-2 · Cited by 203
Self-citationFoster, J. S., Henley, D. C., Bukovsky, A., Seth, P., & Wimalasena, J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.794-810.2001 · Cited by 191
Self-citationEstrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters.
Fuqua, S. A. W., Schiff, R., Parra, I., Moore, J. T., Mohsin, S. K., Osborne, C. K., Clark, G. M., & Allred, D. C. (2003) · PubMed · Cited by 178
Wang, W., Dong, L., Saville, B., & Safe, S. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.8.0323 · Cited by 172
Hodges-Gallagher, L., Cook, J., Lobenhofer, E. K., Li, L., Bennett, L., Bushel, P. R., Aldaz, C. M., Afshari, C. A., & Walker, C. L. (2003) · PubMed · Cited by 133
Watts, C. K. W., Sweeney, K. J. E., Warlters, A., Musgrove, E. A., & Sutherland, R. L. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00689680 · Cited by 131
Mechanisms of Cyclin-Dependent Kinase Inactivation by Progestins
Musgrove, E. A., Swarbrick, A., Lee, C. S. L., Cornish, A. L., & Sutherland, R. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.1812 · Cited by 125
Quantitative analysis of estrogen receptor-? mRNA and its variants in human breast cancers
Iwao, K., Miyoshi, Y., Egawa, C., Ikeda, N., & Noguchi, S. (2000) · International Journal of Cancer · Cited by 125
Bijwaard, K. E., Aguilera, N. S. I., Monczak, Y., Trudel, M., Taubenberger, J. K., & Lichy, J. H. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.2.195 · Cited by 117
Hui, R., Finney, G. L., Carroll, J. S., Lee, C. S. L., Musgrove, E. A., & Sutherland, R. L. (2002) · PubMed · Cited by 109
Foster, J. S., Fernando, R. I., Ishida, N., Nakayama, K. I., & Wimalasena, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302830200 · Cited by 103
Self-citationLack of relationship between CDK activity and G1 cyclin expression in breast cancer cells
Sweeney, K. J. E., Swarbrick, A., Sutherland, R. L., & Musgrove, E. A. (1998) · Oncogene · doi:10.1038/sj.onc.1201814 · Cited by 93
Carroll, J. S., Swarbrick, A., Musgrove, E. A., & Sutherland, R. L. (2002) · PubMed · Cited by 83
Telomerase activity is associated with cell cycle deregulation in human breast cancer.
Landberg, G., Nielsen, N. H., Nilsson, P., Emdin, S. O., Cajander, J., & Roos, G. (1997) · PubMed · Cited by 79
Cell cycle progression without cyclin E/CDK2
Gladden, A. B., & Diehl, J. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00217-4 · Cited by 67
Ström, A., Arai, N., Leers, J., & Gustafsson, J.-Α. (2000) · Oncogene · doi:10.1038/sj.onc.1203990 · Cited by 48
Self-citationLodén, M., Nielsen, N. H., Roos, G., Emdin, S. O., & Landberg, G. (1999) · Oncogene · doi:10.1038/sj.onc.1202488 · Cited by 45
Cdk2 dethroned as master of S phase entry
Hinds, P. W. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00084-9 · Cited by 35
Clinical impact of assay of estrogen receptor βcx in breast cancer
Saji, S., Omoto, Y., Shinizu, C., Horiguchi, S., Watanabe, T., Funata, N., Hayashi, S., Gustafsson, J.-Å., & Toi, M. (2002) · Breast Cancer · doi:10.1007/bf02967608 · Cited by 28
Self-citationLicznar, A., Caporali, S., Lucas, A., Weisz, A., Vignon, F., & Lazennec, G. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01090-1 · Cited by 21
Cited by
Biological determinants of endocrine resistance in breast cancer
Musgrove, E. A., & Sutherland, R. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2713 · Cited by 1,252
The different roles of ER subtypes in cancer biology and therapy
Thomas, C., & Gustafsson, J.-Å. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3093 · Cited by 654
Self-citationShanle, E. K., & Xu, W. (2011) · Chemical Research in Toxicology · doi:10.1021/tx100231n · Cited by 522
Structure–function relationship of estrogen receptor α and β: Impact on human health
Ascenzi, P., Bocedi, A., & Marino, M. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.07.001 · Cited by 499
Current and emerging biomarkers in breast cancer: prognosis and prediction
Weigel, M. T., & Dowsett, M. (2010) · Endocrine-Related Cancer · doi:10.1677/erc-10-0136 · Cited by 496
Metadata
- Authors
- Ström, A., Hartman, J., Foster, J. S., Kietz, S., Wimalasena, J., & Gustafsson, J.-Å.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-01-26
- Volume
- 101
- Issue
- 6
- Pages
- 1566-1571
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2166766053
- Cited by
- 534
- References
- 39
- FWCI
- 14.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.